Antibody Use during an Outbreak of Ebola Virus Disease in the Democratic Republic of Congo, 2020

N Engl J Med. 2022 Mar 24;386(12):1188-1191. doi: 10.1056/NEJMc2113505.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adolescent
  • Adult
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Antiviral Agents / therapeutic use*
  • Child
  • Child, Preschool
  • Democratic Republic of the Congo / epidemiology
  • Disease Outbreaks*
  • Drug Combinations
  • Ebolavirus
  • Female
  • Hemorrhagic Fever, Ebola / drug therapy*
  • Hemorrhagic Fever, Ebola / epidemiology
  • Hemorrhagic Fever, Ebola / mortality
  • Hemorrhagic Fever, Ebola / virology
  • Humans
  • Male
  • Randomized Controlled Trials as Topic
  • Viral Load

Substances

  • Antibodies, Monoclonal, Humanized
  • Antiviral Agents
  • Drug Combinations
  • atoltivimab, maftivimab, and odesivimab-ebgn drug combination
  • ansuvimab